on Tribun Health (EPA:GIB.A)
Tribun Health Secures Over €600,000 in Bpifrance I-Nov Wave 11 Competition for Pathomix Project
PARIS, FRANCE – Tribun Health, renowned for its digital pathology software solutions, has been named a winner in the I-Nov Wave 11 competition by Bpifrance, under the ambitious France 2030 plan. The competition supports innovative leaders like Tribun Health, promoting advanced technologies that transform industries.
The company's Pathomix project is set to enhance diagnostic capabilities through its flagship software, CaloPix, which modernizes traditional pathological analysis with digital solutions. This project will enhance data integration across healthcare and pharmaceutical research, ensuring better data management in compliance with GDPR and HIPAA standards.
By securing €618,000 in funding, comprising grants and repayable advances, Tribun Health aims to enhance its role in oncology diagnostics, crucial for precise medical decisions. This funding will support the development of a sophisticated data query module to improve interoperability and facilitate research and development activities across various health centers.
Bertrand de Fürst, Innovation Director, emphasized the support from French public entities as a validation of Tribun Health's efforts to enhance accessible, cutting-edge medical solutions. Jean-François Pomerol, CEO, further highlighted the project's focus on automating data extraction for research, crucial for advancing precision medicine.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Tribun Health news